2023
2022
-
Skripova V. Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin // Vlasenkova, R., Zhou, Y., Astsaturov, I., Kiyamova, R. Molecules. - 2022. - Vol.27, Is.4. - Art. №1289. https://doi.org/10.3390/molecules27041289
- Firsova D, Levashov I, Reshetnikova D, Analysis of the sodium-dependent phosphate transporter NaPi2b expression in human tumor cell lines//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
-
Bulatova L, Savenkova D, Nurgalieva A, Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells//Frontiers in Molecular Biosciences. - 2022. - Vol.9, Is.. - Art. №895911.
- Minigulova LB, Savenkova D, Skripova V, Topology of sodium-dependent phosphate transporter NaPi2b in live ovarian cancer cells//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2022. - Vol.52, Is.. - .
- Reshetnikova D , Bulatova LF , Skripova V , Effect of disulfide bonds and N-glycosylation on the recognition of the NaPi2b transporter by monoclonal antibodies//ANNALS OF ONCOLOGY. - 2022. - Vol.33, Is.8. - P.S1408-S1408.
-
Topology of sodium-dependent phosphate transporter NaPi2b in live ovarian cancer cells
F_Eur_J_Clin_Investigation___2022______Abstract.pdf -
Bulatova L.F, Skripova V.S, Korotaeva A.V, Recognition of mutant forms of the sodium-dependent phosphate transporter NaPi2b by monoclonal antibodies in ovarian cancer cells [арёяючэртрэшх ьѓђрэђэћѕ єю№ь эрђ№шщ-чртшёшьюую єюёєрђэюую ђ№рэёяю№ђИ№р NaPi2b ьюэюъыюэрыќэћьш рэђшђхырьш т ъыхђърѕ №рър џшїэшър]//Kazan Medical Journal. - 2022. - Vol.103, Is.4. - P.608-616.
- Nurgalieva AK , Khalitova I , Skripova V , The effect of carboplatin on sodium-dependent phosphate transporter NaPi2b expression in the OVCAR-4 ovarian cancer cell line//ANNALS OF ONCOLOGY. - 2022. - Vol.33, Is.8. - P.S1414-S1415.
-
Bulatova L, Savenkova D, Skripova V, Nurgalieva A, Reshetnikova , Timonina A, Anapina A, Korotaeva A, Bogdanov M, Kiyamova R Topology of sodium-dependent phosphate transporter NaPi2b in live ovarian cancer cells. Eur J Clin Invest 52, 112-113 (2022).https://doi.org/10.1111/eci.13796
F_fmolb_09_895911.pdf -
Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells
fmolb_09_895911__1_.pdf - Bulatova Leisan, Savenkova Daria, Reshetnikova Daria, Recognition of cysteine mutant forms of the sodiumdependent phosphate transporter NaPi2b by monoclonal antibodies in ovarian cancer cells OVCAR-8//CELL DEATH DISCOVERY. - 2022. - Vol.8, Is.1. - P.5-6.
2021
-
Bulatova L. F. Structurally constrained tumor-specific epitope within the largest extracellular domain of sodium-dependent phosphate transporter NaPi2b / L.F. Bulatova, V. Skripova, A. Nurgalieva, D. Reshetnikova, D.V. Savenkova, A. Timonina, M.V. Bogdanov, R.G. Kiyamova //ANNALS OF ONCOLOGY. - 2021. - Vol.32, Is.. - P.S368-S369.
- Nurgalieva A. K., Safina S., Shakirova E., Expression of sodium-dependent phosphate transporter NaPi2b is downregulated in malignant ovarian tumors after neoadjuvant chemotherapy//ANNALS OF ONCOLOGY. - 2021. - Vol.32, Is.. - P.S1361-S1362.
-
Nurgalieva A.K. Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer / Nurgalieva AK, Popov VE, Skripova VS, Bulatova LF, Savenkova DV, Vlasenkova RA, Safina SZ, Shakirova EZ, Filonenko VV, Bogdanov MV, Kiyamova RG. // Biochemistry and Biophysics Reports. - 2021. - Vol.28, Is.. - Art. №101104. doi: 10.1016/j.bbrep.2021.101104.
-
R. Vlasenkova, J. Sultanova, V. Skripova, R.G. Kiyamova. 61P Characterization of EMC2 gene as a potential prognostic marker of tumor diseases / Annals of Oncology - Volume 32, Supplement 6, 2021 - Page S1364, https://doi.org/10.1016/j.annonc.2021.08.2057.
2020
-
Savenkova, D.V. Physcion Enhances Sensitivity of Pancreatic Adenocarcinoma and Lung Carcinoma Cell Lines to Cisplatin / D.V. Savenkova, К.V. Havrysh, V.S. , Skripova, N. E. Ionova, A. K. Nurgalieva, L. F. Minigulova, M. V. Bogdanov, R. G. Kiyamova // BioNanoSci. - 2020. - № 10. - P. 549–553
-
Kiyamova R. N-glycosylation status of membrane phosphate transporter NaPi2b is crucial for its epitope recognition by monoclonal antibody in tumour cells / R. Kiyamova, L.F. Minigulova, V. Skripova, A. Nurgalieva, D. Reshetnikova, L. Savinska, V. Filonenko, M. Bogdanov // Annals of Oncology. – 2020. – V. 31. – IS 5): P. S1227-S1228 https://doi.org/10.1016/j.annonc.2020.08.2193
- Minigulova L.F., Skripova V.S., Nurgalieva A.K., Savenkova D.V., Kozlova A.S., Akberova N.I., Reshetnikova D.D., Savinska L.A., Garifulin O.M., Bogdanov M.V., Kiyamova R.G. Recognition of the sodium-dependent phosphate transporter NaPi2b by monoclonal antibodies N-NaPi2b in ovarian cancer cells. Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki, 2020, vol. 162, no. 4, pp. 529–540. doi: 10.26907/2542-064X.2020.4.529-540
- Kiyamova R., Minigulova L. F., Skripova V., N-glycosylation status of membrane phosphate transporter NaPi2b is crucial for its epitope recognition by monoclonal antibody in tumour cells//ANNALS OF ONCOLOGY. - 2020. - Vol.31, Is.. - P.S1227-S1228.
-
Skripova V. CRISPR/Cas9 and bioinformatics approaches revealed new regulators of pancreatic cancer cells platinum sensitivity / V. Skripova, R. Vlasenkova, I. Astsaturov, R. Kiyamova // Annals of Oncology. – 2020. – V. 31. – IS 5): P. S1235-S1236 https://doi.org/10.1016/j.annonc.2020.08.2220
2019
-
Savenkova D.V. The combined action of cisplatin and Physcion increases the ROS level in the lung and pancreas cancer cells /D.V. Savenkova, K. V. Havrysh, V.S. Skripova, A.K. Nurgalieva, L.F. Minigulova, R.G. Kiyamova// Human gene therapy. - 2019. - Volume 30. - Issue 11. - P. A62.
-
L. Minigulova Unusual folding of NaPi2b transporter extramembrane domain 4 during malignant transformation / L.Minigulova, V. Skripova, A.K. Nurgalieva, N. Ionova, D. Reshetnikova, M. Bogdanov, R. Kiyamova// Annals of Oncology. - 2019. - 30 (suppl_9): ix122-ix130.
F_Unusual_folding_of_NaPi2b_transporter_extramembrane_domain_4_during_malignant_transformation___OncologyPRO.pdf
F_Unusual_folding_of_NaPi2b_transporter_extramembrane_domain_4_during_malignant_transformation___OncologyPRO.pdf -
L. Minigulova, V. Skripova, A.K. Nurgalieva, N. Ionova, D. Reshetnikova, M. Bogdanov, R. Kiyamova Unusual folding of NaPi2b transporter extramembrane domain 4 during malignant transformation // Annals of Oncology. - 2019. - 30 (suppl_9): ix122-ix130.
Unusual_folding_of_NaPi2b_transporter_extramembrane_domain_4_during_malignant_transformation___OncologyPRO.pdf - Л.Ф. Минигулова, В.С. Скрипова, А. K. Нургалиева, Д.Д.Решетникова, А.Д. Метелева, М.В. Богданов, Р.Г. Киямова Трансмембранный топогенез и фолдинг экстрамембранных доменов транспортера NaPi2b в условиях злокачественной трансформации может приводить к возникновению опухольспецифических эпитопов // Acta Naturae – 2019 – T.2. – C. 115
- Savenkova D. V., Havrysh K., Skripova V. S., The combined action of cisplatin and Physcion increases the ROS level in the lung and pancreas cancer cells//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A62-A62.
- Minigulova L., Skripova V., Nurgalieva A., Transmembrane topogenesis and folding of extramembrane domains of NaPi2b transporter under conditions of malignant transformation can lead to the appearance of tumor-specific epitopes//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A46-A46.
- Minigulova L., Skripova V., Nurgalieva A. K., Unusual folding of NaPi2b transporter extramembrane domain 4 during malignant transformation//ANNALS OF ONCOLOGY. - 2019. - Vol.30, Is.. - .
- Minigulova L., Akberova N., Kozlova A., Charge balance rule in the assembly of integral membrane proteins in tumor cells//HUMAN GENE THERAPY. - 2019. - Vol.30, Is.11. - P.A46-A47.
2018
-
Skripova, V. Development of a panel of pancreatic cancer cell lines expressing doxycycline inducible spCas9 / V. Skripova, A. Nurgalieva, I. Astsaturov, R. Kiyamova / European Journal of Clinical Investigation. - 2018. - Volume 48, Issue S1, p. 220
F_Poster_Abstract_skripova.pdf - Skripova, V. Application of CRISPR/Cas9 system for identification of genes involved in the regulation of pancreatic cancer cells platinum sensitivity / V. Skripova, I. Serebriiskii, R. Kiyamova, I. Astsaturov // Annals of Oncology. - 2018.
-
Savenkova D. The effect of small molecule compounds Physcion and PFI-3 on the sensitivity of the tumor cell lines SCC61 and AcPC-1 to cisplatin / D. Savenkova, L. Minigulova, K. Havrysh, V. Skripova, I. Serebriiskii, R. Kiyamova / European Journal of Clinical Investigation. - 2018. - Volume 48, Issue S1, p.221
Poster_Abstract_savenkova.pdf -
Savenkova D.V. Investigation of the combined action of cisplatin and 6-phosphogluconate dehydrogenase inhibitor on the model of tumor cell lines / D.V. Savenkova, L.F. Minigulova, К.V. Havrysh, V.S. Skripova, I.G. Serebriiskii, R.G. Kiyamova // Annals of Oncology - 2018. - Volume 29. - Issue suppl_6. - P. vi5.
- Д.В. Савенкова. Влияние ингибирования SMARCA 2/4 на чувствительность опухолевой клеточной линии SCC61 к цисплатину / Д.В. Савенкова , Л.Ф.Минигулова , К.В. Гавриш , В.С.Скрипова , И.Г.Серебрийский, Р.Г.Киямова// Сборник тезисов XIX Зимней молодежной школы по биофизике и молекулярной биологии. - 2018. - С.169
- Nurgalieva A. K., Skripova V. S., Minigulova L. F., Obtaining a Pancreatic Cancer Cell Line Stably Expressing Doxycycline-Dependent Endonuclease Cas9//UCHENYE ZAPISKI KAZANSKOGO UNIVERSITETA-SERIYA ESTESTVENNYE NAUKI. - 2018. - Vol.160, Is.3. - P.386-394.
- V.S. Skripova. Sensitivity of the SCC61 and AsPC-1 tumor cell to cisplatin under Physcion and PFI-3 inhibitors treatment/ V.S. Skripova, A.K. Nurgalieva, R.G.Kiyamova //Abstract book «Kazan precision medicine workshop», Kazan. - September 10-12, 2018. - P. 32
- А.К. Нургалиева. Получение клеточных линий рака поджелудочной железы, стабильно экспрессирующих доксициклин-зависимую эндонуклеазу Cas9 / А.К. Нургалиева , В.С. Скрипова , Л.Ф. Минигулова , Р.Г. Киямова// тезисы Сборник тезисов XIX Зимней молодежной школы по биофизике и молекулярной биологии. - 2018. - С.156
- Skripova V., Nurgalieva A., Astsaturov I., Development of a panel of pancreatic cancer cell lines expressing doxycycline inducible spCas9//EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. - 2018. - Vol.48, Is.. - P.220-220.
2017
- Минигулова Л.Ф. Влияние ингибиторования 6-фосфоглюконатдегидрогеназы на чувствительность линии SCC61 к цисплатину / Минигулова Л.Ф., Скрипова В.С., Киямова Р.Г., Серебрийский И.Г. // Сборник тезисов VI Международной Научно-практической конференции “Новые концепции механизмов воспаления, аутоиммунитета и развития опухоли”, Казанская Государственная Медицинская Академия. - Казань, 2017. - 47 с
-
Skripova V. CRISPR/Cas9 Technique for Identification of Genes Regulating Oxaliplatin Resistance of Pancreatic Cancer Cell Line / /V. Skripova, I. Serebriiskii, Z. Abramova, R. Kiyamova // BioNanoScience. - 2017. - Vol.7, Is.1. - P.97-100.
F_CRISPR_Cas9.pdf - Минигулова Л.Ф. Чувствительность опухолевых клеточных линий к терапии цисплатином в комбинации с ингибитором 6-фосфоглюконатдегидрогеназы / Л.Ф. Минигулова, Д.В. Савенкова, К.В. Гавриш, В.С. Скрипова, И.Г. Серебрийский, Р.Г. Киямова// Успехи молекулярной онкологии. - 2017. - Т.4. - С. 92.
2016
-
Skripov V. Granule Associated DNase in T-Lymphocytes from Patients with Inflammatory Disease /V. Skripov, C.A. Vodoounon, I.D. Reshetnicova, B.B. Legba, Z.I. Abramova // American Journal of Biomedical Research. -2016.- V.4,N.4.-P. 87-93 DOI: 10.12691/ajbr-4-4-2
Granule_Associated_DNase_in_T_Lymphocytes_from.pdf
2013
-
Ganeeva L.A, Skripova V.S, Kasatova L.V, Assessment of some biochemical parameters of energy metabolism in student-athletes after prolonged exercise//Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki. - 2013. - Vol.155, Is.1. - P.40-49.
- Ганеева, Л.А. Оценка некоторых биохимических параметров энергетического обмена у студентов-легкоатлетов после продолжительной нагрузки/ Л.А.Ганеева, В.С. Скрипова, Л.В. Касатова, Р.М.Набиуллина, З.И.Абрамова// Учен. зап. Казан. ун-та. Сер. Естеств.науки. -2013. -Т. 155, кн. 1. -С. 40-49.
2011
| Work address: | 18 Kremlevskaya Str., Kazan, Building #01 (Main building) |
| Office number: | 114в |
| E-mail: | vsk190@gmail.com |
| Google scholar: | https://scholar.google.com/citations?view_op=list_works&hl=ru&user=kCSRArYAAAAJ |
| Experience: |
| Scientific and pedagogical experience: |
| General experience: |
| Experience in KFU: |
